Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia

Clinical trial NCT03957915 · COMPLETED

Trial details

NCT number: NCT03957915
Sponsor: Institut Paoli-Calmettes
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Recurrent Acute Lymphoblastic Leukemia, in Relapse Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukaemia Recurrent Mixed Phenotype Acute Leukemia

Start date: 2020-05-29
Primary completion: 2024-07-15
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.